Molecular identification – Page 4

Treatment and diagnostic challenges associated with the novel and rapidly emerging antifungal-resistant dermatophyte, Trichophyton indotineae

mycolabadmin

A new type of fungal infection called Trichophyton indotineae has emerged and spread globally, particularly from India. It causes widespread skin infections that are difficult to treat because the fungus resists common antifungal medications. Doctors and laboratories need to be aware of this infection to properly identify it and choose effective treatments, especially for patients with travel history to affected regions.

Saksenaea oblongispora Rhinosinusitis in Advanced HIV: A Rare and Lethal Mucormycosis

mycolabadmin

A 32-year-old man with advanced HIV developed a severe fungal infection of his sinuses caused by a rare fungus called Saksenaea oblongispora, which typically doesn’t affect people with HIV. The patient presented with severe facial swelling that rapidly worsened, and despite doctors identifying the fungus through biopsies and lab tests, he did not receive antifungal treatment or surgery before his condition became critical. This is the first case of this particular fungal infection documented in sub-Saharan Africa and in HIV patients, highlighting how dangerous this rare infection can be and how challenging it is to diagnose quickly enough to save lives.

Candidemia due to Candida lambica in a neutropenic oncology patient: A rare case report

mycolabadmin

A 56-year-old cancer patient developed a serious bloodstream infection caused by a rare yeast called Candida lambica despite taking antifungal medications. Doctors identified the infection using genetic sequencing and found that the organism was sensitive to a different antifungal drug called voriconazole. After switching medications and removing the patient’s central line, the infection cleared up. This case demonstrates the importance of accurately identifying fungal infections and testing which medications work best against them.

Epidemiology of mucormycosis in COVID-19 patients in northwest Iran: Rhizopus arrhizus as the predominant species

mycolabadmin

During the COVID-19 pandemic, some patients developed a severe fungal infection called mucormycosis alongside their coronavirus infection. This study found that 63 COVID-19 patients in Iran developed mucormycosis, which primarily affected the sinuses and brain. The researchers identified that a fungus called Rhizopus arrhizus caused most infections, and patients who received corticosteroids (used to treat severe COVID-19) had a higher risk, especially those who developed diabetes from the steroids.

Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles

mycolabadmin

This research examined fungal infections in hospitalized patients with lung diseases in Iran, identifying which fungi were most common and which antifungal medications worked best against them. Researchers found that Candida albicans and Aspergillus flavus were the most prevalent fungi, particularly in COPD patients. Notably, some Candida isolates showed resistance to certain antifungal drugs, particularly voriconazole. The study emphasizes the importance of proper fungal identification and susceptibility testing for effective treatment.

A Rare Case of Alternaria citri Keratitis Successfully Treated with Voriconazole

mycolabadmin

A 71-year-old woodworker developed a serious eye infection caused by a rare fungus called Alternaria citri that damaged his cornea. Doctors identified the fungus using genetic testing and treated it with the antifungal drug voriconazole combined with surgery. After one year, his vision improved and the infection did not return, marking the first documented case of this particular fungal infection in humans.

Shifting etiological agents of dermatophytosis: a molecular epidemiological study from Iran

mycolabadmin

Researchers in Iran studied fungal infections of the scalp and nails using modern DNA testing methods. They found that the main fungus causing scalp infections (T. tonsurans) remains the most common, but a new species (T. indotineae) is increasingly causing nail infections and is resistant to common antifungal medicines. The study shows that traditional identification methods often misidentify these fungi, highlighting the importance of molecular testing for accurate diagnosis and treatment.

First case report of tinea corporis caused by Trichophyton indotineae in Latin America

mycolabadmin

A 21-year-old woman in Argentina developed a persistent skin infection caused by a fungus called Trichophyton indotineae, likely acquired during travel to Mexico. The infection did not respond to common antifungal medications like terbinafine, but responded well to treatment with a special formulation of itraconazole that was completely effective within four weeks. This case represents the first documented occurrence of this emerging fungal pathogen in Latin America and highlights the importance of molecular identification when standard treatments fail.

Simultaneous Detection of Four Madurella Species Using Loop-Mediated Isothermal Amplification (LAMP) for Eumycetoma Diagnosis

mycolabadmin

Scientists developed a simple new test to identify four types of fungi that cause a serious tropical disease called eumycetoma. Unlike previous tests that required expensive equipment and multiple reactions, this new test works in one tube using simple heating instead of complex thermal cycling. The test can detect the fungi in about 45 minutes and works reliably in remote areas with limited resources.

The first report of rhinosinusitis by Rhizopus delemar in a patient with severe COVID-19 in Iran: a case report

mycolabadmin

A 63-year-old man hospitalized with COVID-19 developed a serious fungal sinus infection caused by a rare mold called Rhizopus delemar. Despite surgery to remove infected tissue and treatment with antifungal medication amphotericin B, the infection spread and the patient died after five weeks. This was the first documented case of this particular mold causing sinus infection in a COVID-19 patient in Iran, highlighting how severe fungal infections can occur as dangerous complications of COVID-19.

Research Topic: Molecular identification